Related Experiment Videos
Clinical management of malignant hyperpyrexia
Journal of Pediatric Surgery
|October 1, 1976
Abstract:
Experience with eight cases of malignant hyperpyrexia are presented. The different types are described and illustrated by clinical cases. Early recognition of this condition is the cornerstone in the successful management of the complication. Early diagnosis and methods of treatment are described.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abdominal pain and appendicitis: is there a difference in referrals between HMO pediatricians and private pediatricians?
Journal of pediatric surgery·2000
'Spontaneous' neonatal gastric perforation: is it really spontaneous?
Journal of pediatric surgery·2000
Is it necrotizing enterocolitis, microcolon of prematurity, or delayed meconium plug? A dilemma in the tiny premature infant.
Journal of pediatric surgery·1996
Is early fascial closure necessary for omphalocele and gastroschisis?
Journal of pediatric surgery·1995
Allopurinol protects the bowel from necrosis caused by indomethacin and temporary intestinal ischemia in mice.
Journal of pediatric surgery·1993
Role of adenosine in the diagnosis and treatment of postoperative supraventricular tachyarrhythmias.
Journal of clinical anesthesia·1993
Regional Anaesthetic Techniques in Laparoscopic Inguinal Hernia Repair in Children: A Systematic Review.
Journal of pediatric surgery·2026
STANDING ON THE SHOULDERS OF GIANTS: A BRIEF HISTORY OF HIRSCHSPRUNG DISEASE.
Journal of pediatric surgery·2026
Long-Term Outcomes of Biliary Atresia in Korea: A Nationwide Multicenter Cohort Study (2012-2021).
Journal of pediatric surgery·2026
Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
British journal of cancer·2026
Individual and systems level factors associated with odds of orchiectomy in testicular torsion in New York State.
Journal of pediatric urology·2026
USP11 exacerbates intestinal I/R injury by driving NCOA4-mediated ferritinophagy and ferroptosis via Beclin-1 deubiquitination.
International immunopharmacology·2026